Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Characteristics and Determinants of Central Sensitization of Nociception in Fibromylagic Syndrome

NCT04624581 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT04624581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04624581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Characteristics and Determinants of Central Sensitization of Nociception in Fibromylagic Syndrome
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2020
Completion date
January 17, 2022
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia